Showing 581 - 600 results of 51,774 for search '(( 50 ((((ng decrease) OR (we decrease))) OR (a decrease)) ) OR ( 6 b decrease ))', query time: 1.04s Refine Results
  1. 581
  2. 582

    Bioluminescence decreased following <i>ex vivo</i> collagenase digestion of transgenic femora. by Sarah E. Mailhiot (766685)

    Published 2015
    “…<p>Femora from tamoxifen treated transgenic mice were degraded in collagenase. (A) The femur showed a linear decrease (r = -0.619, p = 0.0452) after 6 hours in digestion. …”
  3. 583
  4. 584
  5. 585
  6. 586
  7. 587

    DHT increases whereas orchidectomy decreases the weight and cross sectional area of hindlimb muscles. by Young-Eun Yoo (323357)

    Published 2013
    “…<b>A:</b> In WT mice, DHT increased the GN weight by 7% (212.4±8.8 mg), whereas orchidectomy decreased it by 14% (171.4±9.0 mg) compared with control WT mice (198.4±5.5 mg). …”
  8. 588
  9. 589
  10. 590
  11. 591
  12. 592
  13. 593

    Decreased ISCs and increased goblet cells after intestinal specific loss of MLL1. by Neha Goveas (11790822)

    Published 2021
    “…<p><b>(A)</b> Kaplan-Meier survival curve. Tamoxifen was given by gavage for 6 days to mice with the genotype <i>Mll1</i><sup><i>FC/+; Vil-Cre-ERT2/+</i></sup> (n = 12) and <i>Mll1</i><sup><i>FC/FC; RC/+</i></sup> (n = 18). …”
  14. 594
  15. 595

    Ofd1 protection of photoreceptors from oxidative stress via decreasing ROS production. by Juan Wang (115708)

    Published 2016
    “…NC: normal control. * p<0.05. n = 6. (C) These results showed that the SOD and CAT activities decreased by 40% and 30% in MNU-treated cells (MNU), but was partially attenuated by Ofd1 overexpression (Ofd1-CDS+MNU). …”
  16. 596
  17. 597

    Image_1_Electroencephalographic Evidence for Individual Neural Inertia in Mice That Decreases With Time.JPEG by Andrzej Z. Wasilczuk (11945885)

    Published 2022
    “…EEG was measured after induction of and emergence from isoflurane administered near the EC<sub>50</sub> dose for loss of righting in genetically inbred mice on a timescale that minimizes pharmacokinetic confounds. …”
  18. 598
  19. 599
  20. 600